0001217234-21-000018.txt : 20210115
0001217234-21-000018.hdr.sgml : 20210115
20210115172105
ACCESSION NUMBER: 0001217234-21-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210114
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King Sasha
CENTRAL INDEX KEY: 0001721150
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 21533083
MAIL ADDRESS:
STREET 1: C/O CAREDX, INC.
STREET 2: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wf-form4_161074925300821.xml
FORM 4
X0306
4
2021-01-14
0
0001217234
CareDx, Inc.
CDNA
0001721150
King Sasha
C/O CAREDX, INC.
1 TOWER PLACE, 9TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Commercial Officer
Common Stock
2021-01-14
4
M
0
833
1.07
A
44264
D
Common Stock
2021-01-14
4
M
0
2500
5.90
A
46764
D
Common Stock
2021-01-14
4
M
0
417
2.80
A
47181
D
Common Stock
2021-01-14
4
M
0
750
1
A
47931
D
Common Stock
2021-01-14
4
M
0
3125
12.24
A
51056
D
Common Stock
2021-01-14
4
M
0
1250
6.31
A
52306
D
Common Stock
2021-01-14
4
M
0
1000
27.17
A
53306
D
Common Stock
2021-01-14
4
S
0
700
85.2372
D
52606
D
Common Stock
2021-01-14
4
S
0
1400
86.4594
D
51206
D
Common Stock
2021-01-14
4
S
0
2601
87.5623
D
48605
D
Common Stock
2021-01-14
4
S
0
5174
88.1585
D
43431
D
Employee Stock Option (right to buy)
1.07
2021-01-14
4
M
0
833
0
D
2027-06-09
Common Stock
833.0
1042
D
Employee Stock Option (right to buy)
5.9
2021-01-14
4
M
0
2500
0
D
2027-10-27
Common Stock
2500.0
8333
D
Employee Stock Option (right to buy)
2.8
2021-01-14
4
M
0
417
0
D
2027-09-01
Common Stock
417.0
1111
D
Employee Stock Option (right to buy)
1.0
2021-01-14
4
M
0
750
0
D
2027-04-21
Common Stock
750.0
750
D
Employee Stock Option (right to buy)
12.24
2021-01-14
4
M
0
3125
0
D
2028-06-29
Common Stock
3125.0
17708
D
Employee Stock Option (right to buy)
6.31
2021-01-14
4
M
0
1250
0
D
2028-01-19
Common Stock
1250.0
5417
D
Employee Stock Option (right to buy)
27.17
2021-01-14
4
M
0
1000
0
D
2029-02-04
Common Stock
1000.0
8333
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.76 to $85.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $85.99 to $86.915, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $87.06 to $88.03, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $88.06 to $88.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
/s/ Peter Maag, as attorney-in-fact for Sasha King
2021-01-15